Global Systemic Lupus Erythematosus Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Genetic disorders Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
Global Musculoskeletal Symptoms Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Parkinson's Disease Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Clostridium difficile Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Psychiatry Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
700 |
Global |
$2,995.00 |
|
Global Non-Hodgkin Lymphoma Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Obesity Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Esophageal Reflux Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials |
Sep 1 2018 |
457 |
Global |
$2,995.00 |
|
Global Transplantation Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Dermatology Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
Global Osteoporosis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Migraine Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Dengue Fever Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
Global Acute and Chronic Myelogenous Leukemia Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Attention Deficit Disorder Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Gastrointestinal Symptoms Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global In Vitro Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
660 |
Global |
$2,995.00 |
|
Global Central Nervous System Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
600 |
Global |
$3,495.00 |
|
Global Osteoarthritis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Multiple Sclerosis Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Accident & Emergency Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Fungal Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Obstetrics Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
200 |
Global |
$2,995.00 |
|
Global Solid Tumor Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
Global Anxiety Partnering 2012-2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Inflammatory Bowel Disease Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
Global Cancer Diagnostics Partnering 2012-2018: Deal trends, players, financials and forecasts |
Sep 1 2018 |
700 |
Global |
$2,995.00 |
|